Company Profile
Beijing Centergate Technologies (holding) provides the production and sale of topical reagents, tablets, injections in China. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment.
Its portfolio also includes Naltrexone Hydrochloride tablets and injections to block the pharmacological effects of exogenous opioids, Acetaminophen and oxycodone tablets and injections for the treatment of moderate to severe pain, tramadol hydrochloride tablets and injections to treat pain in adults, aprolol hydrochloride for the treatment of hypertension, angina pectoris, tachycardia-induced arrhythmia, and tremor, buspirone hydrochloride tablets to treat various anxiety disorders, oxycodone hydrochloride extended-release tablets, and Ambroxol hydrochloride injection for the treatment of acute exacerbations of chronic bronchitis, wheezing bronchitis, and bronchial asthma, as well as Febuxostat tablets for the treatment of hyperuricemia.
Its portfolio also includes Bromhexine Hydrochloride injection to treat asthma, bronchiectasis, and silicosis, Metoprolol succinate raw material, Bisoprolol Amlodipine tablets for hypertension, Sitagliptin/Metformin tablets are used for type 2 diabetes patients, Bisoprolol fumarate tablets for the treatment of hypertension, coronary, and artery diseases, and Tropanestone mesylate injection for the treatment of nausea and vomiting.
Additionally, it offers Sildenafil lozenges, Benzyl nonyl hydrochloride tablets, Oxycodone Hydrochloride injection, Bifonazole cream, Huperzine A tablets, Wujia Biochemical capsules, Lactobacillus tablets, Tramadol acetaminophen tablets, Tramadol hydrochloride raw material, Clindamycin phosphate to treat bacterial vaginosis, Piracetam injection, Acanthopanax senticosus, Benidipine Hydrochloride for the treatment of hypertension and angina pectoris, Glipizide Dispersible tablets, and Compound Pancreatic Enzyme powders. Founded in 1999, Beijing Centergate Technologies (holding) is based in Beijing, China.